Overview

Single Dose Study Of The Effect Of Cyclosporine On The Pharmacokinetics Of PF-04991532 In Health Volunteers

Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate the pharmacokinetics, safety and tolerability of a single dose of PF-04991532 in healthy adult subjects with and without co-administration of cyclosporine.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Treatments:
6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid
Cyclosporine
Cyclosporins
Niacin
Nicotinic Acids